Related Experiment Videos

Lack of association of CCR gene polymorphisms and left ventricular hypertrophy in essential hypertension

M Mettimano1, M L Specchia, G La Torre

  • 1Hypertension Center of the Catholic University Medical School, Rome, Italy. mamettim@tin.it

British Journal of Biomedical Science
|October 4, 2005
PubMed

Insights

This study explored the genetic links between left ventricular hypertrophy (LVH) and chemokine receptor gene variants. No significant association was found between CCR5delta32 or CCR264I polymorphisms and LVH in essential hypertensive patients.

Area of Science:

  • Cardiology
  • Genetics
  • Hypertension Research

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for cardiac damage.
  • Genetic factors are implicated in LVH development, but their specific roles remain unclear.
  • Chemokine receptors (CCR) are involved in inflammatory processes relevant to cardiovascular health.

Purpose of the Study:

  • To investigate the potential association between LVH and two specific chemokine receptor gene polymorphisms: CCR5delta32 and CCR264I.
  • To clarify the genetic underpinnings of LVH in essential hypertensive individuals.

Main Methods:

  • Study included 118 essential hypertensive outpatients (grade I-II, aged 27-54).
  • Collected clinical data included office blood pressure and M-mode/2D echocardiography.
  • Statistical analysis was performed to assess the relationship between CCR gene polymorphisms and LVH.

Main Results:

  • The study found no statistically significant association between the CCR5delta32 polymorphism and LVH.
  • Similarly, no significant association was observed between the CCR264I polymorphism and LVH.
  • These findings suggest these specific CCR gene variants may not be major determinants of LVH in this population.

Conclusions:

  • The investigated CCR gene polymorphisms (CCR5delta32 and CCR264I) do not appear to be significantly associated with left ventricular hypertrophy in essential hypertensive patients.
  • Further research is needed to fully elucidate the genetic landscape of LVH.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...